The biggest mistake investors could make this reporting season, or this year for that matter, is underestimating stocks that have already run hard over the past 12 months.

That's according to FNArena's Rudi Filapek-Vandyck, who believes we are now in a period of innovation and revolution similar to the Roaring '20s.

"The 1920s was this great era of technological innovation, which also meant it was a great era to be a shareholder. And a lot of companies, of course, had tremendous growth on the back of new developments that were re-shaping society, the share market and economies," he says.

"We are going through a similar phase now and as a consequence, high growth driven by megatrends and technological innovation is not going to go away... Those companies will continue to perform, and they will never be priced at nine times next year's profits."

With this in mind, Rudi has been cycling some of his cash - which once sat at 18% of his portfolio - into stocks like WiseTech Global (ASX: WTC), REA Group (ASX: REA), HUB24 (ASX: HUB), ResMed (ASX: RMD) and Goodman Group (ASX: GMG).

In this interview, Rudi shares what he believes investors can expect over the coming reporting season, the companies that should be on your radar where expectations continue to soar higher, as well as why he believes investors should get their heads out of the charts and focus on fundamentals instead.

Plus, he also names one stock that he argues could be in for a ResMed-like recovery in the coming months.

Note: This interview was recorded on Wednesday 7 February 2024.

https://www.livewiremarkets.com/wires...